synthetic peptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-03-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
==== De novo motif recognition from protein ==== In 2018, a Markov random field approach has been proposed to infer DNA motifs from DNA-binding domains of proteins. Motif Discovery Algorithms Motif discovery algorithms use diverse strategies to uncover patterns in DNA sequences. Integrating enumerative, probabilistic, and nature-inspired approaches, demonstrate their adaptability, with the use of multiple methods proving effective in enhancing identification accuracy. Enumerative Approach: Initiating the motif discovery journey, the enumerative approach witnesses algorithms meticulously generating and evaluating potential motifs. Pioneering this domain are Simple Word Enumeration techniques, such as YMF and DREME, which systematically go through the sequence in search of short motifs. Complementing these, Clustering-Based Methods such as CisFinder employ nucleotide substitution matrices for motif clustering, effectively mitigating redundancy. Concurrently, Tree-Based Methods like Weeder and FMotif exploit tree structures, and Graph Theoretic-Based Methods (e.g., WINNOWER) employ graph representations, demonstrating the richness of enumeration strategies. Probabilistic Approach: Diverging into the probabilistic realm, this approach capitalizes on probability models to discern motifs within sequences. MEME, a deterministic exemplar, employs Expectation-Maximization for optimizing Position Weight Matrices (PWMs) and unraveling conserved regions in unaligned DNA sequences.
Heseltine was unhappy at the way defence contracts were often awarded on a cost-plus basis (i.e. agreeing to pay the supplier a certain amount over and above his costs, leaving no incentive to keep costs to a minimum). In 1985 he promoted his special adviser Peter Levene to be Chief of Defence Procurement; special arrangements had to be made to ensure that Levene did not make decisions affecting his own defence company United Scientific Holdings, of which the former Permanent Secretary Sir Frank Cooper was now chairman, and he was paid £95,000 per annum plus £12,000 in pension contributions, more than the prime minister or senior civil servants. Thatcher agreed to Levene's appointment over civil service objections. He abolished cost-plus pricing of contracts and stated that he had trimmed 10% off the defence equipment budget by 1989 through greater competitive tendering; enough, as Heseltine put it, to pay for the Trident nuclear missile programme. It had been agreed to spend £280m for two Type 22 frigates. Norman Tebbit (Trade and Industry Secretary), with the backing of the Cabinet, wanted them built at Swan Hunter in the North East, but Heseltine threatened resignation in January 1985 unless at least one was built at Cammell Laird on Merseyside, at a cost of an extra £7 million, where Type 22s had been built before. Thatcher let him have his way after he persuaded her that it would reward shipyard workers who had crossed picket lines during a recent strike, but was privately furious, and keen to keep defence costs down in future by buying American equipment.
== Awards == Gold Medal of the Society for Magnetic Resonance in Medicine (1989) GE Coolidge Fellow and Medal, (1990) GE Gold (1989), Silver (1985) and Bronze (1982) patent medallions Editors recognition awards from Radiology (1986, 1988, 1989, 1990) GE Dushman Award (1983) Associate editor, Magn Reson Med (1983-2004), deputy editor (2010-2025) Editorial boards of Magn Reson Imag (1982–present), Rev Sci Instrum (1986-1988), and Radiology (1991-5) Editorial board of Advanced Medicine (Japan: 1995–); MAGMA (2003–2006) Elected trustee, Soc Magn Reson Med (1986-1989), and Soc Magn Reson Imag (1982-1986) Fellow, Soc Magn Reson (1989) Gold Medal of the American Roentgen Ray Society (2015) Distinguished investigator, Academy of Radiology Research (2012) Member, National Academy of Inventors (2015) Soc Magn Reson Med Sir Peter Mansfield Lecturer (2012) NIH grant reviewer since 1979
Sources: en.wikipedia.org
Ningxia Provincial Government Archived 15 April 2012 at the Wayback Machine Ningxia at the Encyclopædia Britannica Economic profile for Ningxia at HKTDC Ningxia Profile – UNESCAP Archived 16 January 2014 at the Wayback Machine Ningxia Profile – China Economic Information Network
=== Viral assembly === Genetically engineered M13 bacteriophage viruses allow preparation of quantum dot biocomposite structures. It had previously been shown that genetically engineered viruses can recognize specific semiconductor surfaces through the method of selection by combinatorial phage display. Additionally, it is known that liquid crystalline structures of wild-type viruses (Fd, M13, and TMV) are adjustable by controlling the solution concentrations, solution ionic strength, and the external magnetic field applied to the solutions. Consequently, the specific recognition properties of the virus can be used to organize inorganic nanocrystals, forming ordered arrays over the length scale defined by liquid crystal formation. Using this information, Lee et al. (2000) were able to create self-assembled, highly oriented, self-supporting films from a phage and ZnS precursor solution. This system allowed them to vary both the length of bacteriophage and the type of inorganic material through genetic modification and selection.
HLA-DM (human leukocyte antigen DM) is an intracellular protein involved in the mechanism of antigen presentation on antigen presenting cells (APCs) of the immune system. It does this by assisting in peptide loading of major histocompatibility complex (MHC) class II membrane-bound proteins. HLA-DM is encoded by the genes HLA-DMA and HLA-DMB. HLA-DM is a molecular chaperone that works in lysosomes and endosomes in cells of the immune system. It works in APCs like macrophages, dendritic cells, and B cells by interacting with MHC class II molecules. HLA-DM protects the MHC class II molecules from breaking down, and regulates which proteins or peptides bind to them as well. This regulates how and when a peptide acts as an antigen initiating an immune response. Thus, HLA-DM is necessary for the immune system to respond effectively to a foreign invader. Impairment in HLA-DM function can result in immunodeficiency and autoimmune diseases.
They have a cloaca into which the urinary and genital passages open, but not a swim bladder. Cartilaginous fish produce a small number of large, yolky eggs. Some species are ovoviviparous and the young develop internally but others are oviparous and the larvae develop externally in egg cases. The bony fish lineage shows more derived anatomical traits, often with major evolutionary changes from the features of ancient fish. They have a bony skeleton, are generally laterally flattened, have five pairs of gills protected by an operculum, and a mouth at or near the tip of the snout. The dermis is covered with overlapping scales. Bony fish have a swim bladder which helps them maintain a constant depth in the water column, but not a cloaca. They mostly spawn a large number of small eggs with little yolk which they broadcast into the water column.
Sources: en.wikipedia.org
=== Low-throughput === The mentioned drawbacks limit the reasonable use of automated in-gel digestion systems to the routine laboratory whereas the research laboratory with a demand to make a flexible use of the instruments of protein identification more often stays with the manual, low-throughput methods for in-gel digestion and MS analysis. This group of customers is targeted by the industry with several kit systems for in-gel digestion. Most of the kit systems are mere collections of the chemicals and enzymes needed for the in-gel digestion whereas the underlying protocol remains unchanged from the manual standard procedure described above. The advantage of these products for the inexperienced customer lies in the guaranteed functioning of the diverse solutions in combination with a ready-made protocol for the process. A few companies have tried to improve the handling process of in-gel digestion to allow even with manual sample preparation an easier and more standardised workflow. The Montage In-Gel Digest Kit from Millipore is based on the standard protocol, but enables processing of a large number of parallel samples by transferring the handling of the gel pieces to a modified 96 well microplate. The solutions for the diverse steps of in-gel digestion are pipetted into the wells of this plate whereas the removal of liquids is performed through the bottom of the wells by a vacuum pump. This system simplifies the handling of the multiple pipetting steps by the use of multichannel pipettes and even pipetting robots.
Deman acknowledges that Wolverine is a gruff loner who often takes leave from the X-Men to deal with personal issues or problems, irreverent and rebellious towards authority figures, and displays a wry, sarcastic sense of humor. Despite this, Deman also notes that Wolverine is a reliable ally and competent leader, as well as capable of warmth, compassion, and empathy. Clinical psychologist and Navy veteran Larry Yarbrough recognizes that while "Logan has an extremely reactive temper" he is "also a kind person", pointing out that the "violent/kind demeanor" he displays is typical of combat veterans. According to him, Wolverine's "violent mood swings are a symptom of trauma, not a reflection of his character". He also observes Wolverine's habitual smoking and drinking, which are coping mechanisms for his traumatic experiences. Psychologist Suzana E. Flores writes that Wolverine demonstrates clinical psychological symptoms of post-traumatic stress disorder, bipolar disorder, antisocial personality disorder, dissociative disorder, and even sociopathy, but does so in a way that can be understood and empathized. She interprets his origin story as a depiction of complex childhood trauma, and its effects of dissociative amnesia and hypervigilance. She argues that his first formative trauma was his poor relationship with his mother, who was unable to properly attach to him because she lost her first son. In adulthood, he also suffered the trauma of torture by the Weapon X program.
Ag+ + NO−3 + K+ + Cl− → AgCl↓ + K+ + NO−3 Potassium is quantified using hexachloroplatinic acid as the precipitating agent. Treatment of a solution containing K+ ions with an excess of this platinic acid quantitatively affords of potassium hexachloroplatinate, which is easily weighed and is non-hygroscopic:
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.